Literature DB >> 8780574

Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on noncirrhotic livers.

M Minami1, K Poussin, M Kew, T Okanoue, C Bréchot, P Paterlini.   

Abstract

BACKGROUND & AIMS: Hepatitis B virus genomes have been detected in hepatocellular carcinoma developed without the pretumoral step of cirrhosis; this finding is consistent with a direct effect of the virus in liver cell transformation. The aim of this study was to investigate the molecular bases for the hepatitis B virus persistence. Three hepatitis B surface antigen-positive and 2 hepatitis B surface antigen-negative patients with hepatocellular carcinoma and without cirrhosis were studied for precore/core mutations in tumorous and nontumorous tissues.
METHODS: The precore/core region was amplified and analyzed both by cloning and sequencing and by direct sequencing.
RESULTS: Nonsynonymous mutations were identified selectively in tumorous tissues. Clusters of mutations were identified in the viral encapsidation (epsilon) signal, in immunodominant epitopes of the core protein, and in the polymerase. Common associated point mutations were found in 3 patients infected with hepatitis B virus genotype A in the epsilon signal and in the polymerase gene.
CONCLUSIONS: Precore/core mutations located in domains involved in hepatitis B virus replication and immune response to the virus were identified. The selective presence of some of these mutations in tumorous tissues is consistent with their role in the persistence of the virus in neoplastic cells and, possibly, in liver oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780574     DOI: 10.1053/gast.1996.v111.pm8780574

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

2.  Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma.

Authors:  Y-H Ni; M-H Chang; H-Y Hsu; D-J Tsuei
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 3.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

4.  Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen.

Authors:  P C Tai; D Banik; G I Lin; S Pai; K Pai; M H Lin; G Yuoh; S Che; S H Hsu; T C Chen; T T Kuo; C S Lee; C S Yang; C Shih
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma.

Authors:  Pisit Tangkijvanich; Pattaratida Sa-Nguanmoo; Varocha Mahachai; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Hepatol Int       Date:  2010-07-31       Impact factor: 6.047

Review 6.  Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphate.

Authors:  H Bécheur; D Valla; M A Loriot; A Attar; F Bloch; J P Petite
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

7.  Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion.

Authors:  Sophie Le Pogam; Chiaho Shih
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  The role of mutations in core protein of hepatitis B virus in liver fibrosis.

Authors:  Ashraf Mohamadkhani; Ferdous Rastgar Jazii; Hossein Poustchi; Omidreza Nouraein; Shahsanam Abbasi; Masoud Sotoudeh; Ghodratollah Montazeri
Journal:  Virol J       Date:  2009-11-26       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.